Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3 beta-hydroxysteroid dehydrogenase gene. 1995

F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
INSERM U-329, Université de Lyon, France.

Recently, the structure of two genes encoding isoenzymes responsible for 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase (3 beta HSD) activity in the human was elucidated. This activity is an essential step in the biosynthesis of all classes of steroid hormones. In the classic severe form of 3 beta HSD deficiency, patients present with adrenal insufficiency, various degrees of salt loss, and incomplete masculinization in males. Here we report the characterization of the molecular basis of congenital adrenal hyperplasia due to 3 beta HSD deficiency in a male pseudohermaphrodite born from consanguineous parents and having no clinical salt loss. To analyze the structure of the type I and II 3 beta HSD genes of the patient, DNA fragments, generated by polymerase chain reaction amplification of the four exons and the exon-intron boundaries of these genes, were directly sequenced. The patients carried a homozygous missense mutation converting Asn100 to Ser in exon 3 of his type II 3 beta HSD gene. His parents were heterozygous for the same point mutation. The absence of clinical salt loss associated with a male pseudohermaphroditism suggested that 3 beta HSD activity was impaired to different levels in the testes and adrenal. To elucidate whether this N100S missense mutation affected preferentially a steroidogenic pathway, enzymatic activity was analyzed by in vitro analysis of mutant recombinant enzyme generated by site-directed mutagenesis after its transient expression in COS-1 cells. Using homogenates from transfected cells, the N100S 3 beta HSD enzyme showed a Km value for pregnenolone of 25 +/- 3 mumol/L compared with 3.5 +/- 0.2 mumol/L for the normal human type II 3 beta HSD enzyme. Similar results were obtained using dehydroepiandrosterone as substrate. In addition to decreasing apparent affinity, the N100S mutation decreased the relative specific activity (Vmax), leading to a relative specificity (relative Vmax/Km) 2.7% and 11% that of normal type II 3 beta HSD using pregnenolone or dehydroepiandrosterone as substrate, respectively. Moreover, the mutant N100S protein had an apparent decreased affinity for NAD+, with a Km value of 650 +/- 66 mumol/L compared with 20 +/- 2 mumol/L for normal type II 3 beta HSD. Except for the hypothetical effect of local factors, these findings suggest that a very weak residual activity of the normal type II 3 beta HSD enzyme could prevent salt loss, but it was insufficient for normal male sex differentiation.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008322 Mammals Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young. Mammalia,Mammal
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003241 Consanguinity The magnitude of INBREEDING in humans. Inbreeding, Human,Consanguineous Marriage,Consanguinous Mating,Consanguineous Marriages,Consanguinities,Consanguinous Matings,Human Inbreeding,Human Inbreedings,Inbreedings, Human,Marriage, Consanguineous,Marriages, Consanguineous,Mating, Consanguinous,Matings, Consanguinous
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D005260 Female Females

Related Publications

F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
April 1993, The Journal of steroid biochemistry and molecular biology,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
December 1987, Journal of steroid biochemistry,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
April 1994, Journal of molecular endocrinology,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
September 1998, European journal of endocrinology,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
March 1994, The Journal of clinical endocrinology and metabolism,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
April 1983, The Journal of clinical endocrinology and metabolism,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
May 2003, Medicina clinica,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
April 1995, Human molecular genetics,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
December 1985, Acta endocrinologica,
F Mébarki, and R Sanchez, and E Rhéaume, and N Laflamme, and J Simard, and M G Forest, and F Bey-Omar, and M David, and F Labrie, and Y Morel
September 2000, Medicine,
Copied contents to your clipboard!